Volume | 609,601 |
|
|||||
News | - | ||||||
Day High | 5.73 | Low High |
|||||
Day Low | 4.86 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Annovis Bio Inc | ANVS | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.47 | 4.86 | 5.73 | 5.18 | 5.45 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,758 | 609,601 | $ 5.25 | $ 3,197,859 | - | 4.86 - 22.49 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:58:18 | 20 | $ 5.29 | USD |
Annovis Bio (ANVS) Options Flow Summary
Annovis Bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
53.16M | 10.26M | - | 0 | -56.2M | -5.48 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Annovis Bio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANVS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 13.71 | 20.00 | 4.86 | 7.63 | 2,912,738 | -8.43 | -61.49% |
1 Month | 10.89 | 20.00 | 4.86 | 8.33 | 892,806 | -5.61 | -51.52% |
3 Months | 11.10 | 20.00 | 4.86 | 9.04 | 461,954 | -5.82 | -52.43% |
6 Months | 6.20 | 22.49 | 4.86 | 10.28 | 377,445 | -0.92 | -14.84% |
1 Year | 13.95 | 22.49 | 4.86 | 10.34 | 207,183 | -8.67 | -62.15% |
3 Years | 22.20 | 132.00 | 4.86 | 41.50 | 274,426 | -16.92 | -76.22% |
5 Years | 8.9875 | 132.00 | 2.418 | 32.41 | 272,655 | -3.71 | -41.25% |
Annovis Bio Description
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. |